000 01518nam a2200445 i 4500
001 on1082870012
003 OCoLC
005 20190213083643.0
006 m o d f
007 cr mn|||||||||
008 190118s2017 vaua ob f000 0 eng c
040 _aGPO
_beng
_erda
_epn
_cGPO
_dMvI
042 _apcc
043 _an-usc--
074 _a0967-L-02 (online)
086 0 _aJ 24.32:OP 3
099 _aJ 24.32:OP 3
245 0 4 _aThe opioid threat in the Chicago Field Division.
264 1 _a[Arlington, Va.] :
_bDrug Enforcement Administration,
_c2017.
300 _a1 online resource (17, [1] pages) :
_bcolor illustrations.
336 _btxt
337 _bc
_2rdamedia
338 _bcr
_2rdacarrier
490 1 _aDEA intelligence report
500 _a"June 2017."
500 _a"DEA-CHI-DIR-023-17."
500 _a"Unclassified."
500 _aCRDP Program record.
504 _aIncludes bibliographical reference (page 17).
588 _aDescription based on online resource, PDF version; title from cover (DEA, viewed January 2, 2019).
650 0 _aOpioids.
650 0 _aOpioid abuse
_zMiddle West.
650 0 _aHeroin
_zMiddle West.
650 0 _aHeroin abuse
_zMiddle West.
650 0 _aDrug abuse
_zMiddle West.
650 0 _aDrug dealers
_zMiddle West.
710 1 _aUnited States.
_bDrug Enforcement Administration,
_eissuing body.
830 0 _aDEA intelligence report.
856 4 0 _uhttps://purl.fdlp.gov/GPO/gpo114549
999 _c279043
_d279043